Blood thinners during heart valve or left atrial appendage procedures
Part of Heart & circulation clinical trials.
This study compares different ways of using blood thinners during procedures to fix a leaky mitral valve or close the left atrial appendage. The goal is to find the safest approach to prevent strokes and bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a procedure to repair a leaky mitral valve (using MitraClip or Pascal) or to close the left atrial appendage (using Watchman or Amplatzer).
- You are willing to follow the study schedule and attend follow-up visits.
- You are willing to give written consent to participate.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use two forms of birth control.
- You do not have a bleeding or clotting disorder, and you are not on certain blood thinners too close to the procedure.
- You can have an MRI (no metal implants, no claustrophobia, no pacemaker or defibrillator that would be unsafe).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
This study tests different ways to use blood thinners after a minimally invasive heart valve repair procedure. It may help patients who need long-term blood thinning to prevent clots or stroke.
This trial tests a small clip placed in the ear to help prevent blood clots in the heart for people with heart valve disease. It aims to reduce the risk of stroke and other complications.
This trial compares which two medicines work best after a device closes off a part of the heart called the left atrial appendage. It may help reduce stroke risk while balancing bleeding risk after your procedure.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.